-
Molecular Docking of Proposed Inhibitors for a Metalloprotease Associated with Schitosoma mansoni Infection
Vol 1, 2020 -130098 -
Synthesis and Pharmacological Evaluation of 1,5-diaryl-3-amine-1,2,4-triazoles designed as cholinesterase inhibitors for Alzheimerx0092s Disease treatment
Vol 1, 2020 -129841 -
Synthesis and Pharmacological Evaluation of New 3-(Imidazo[1,2-a]pyridin-2-yl)-coumarins as Cholinesterase Inhibitors
Vol 1, 2020 -129839 -
Synthesis and evaluation of potential antitumor of new acridines-thiosemicarbazones derivatives.
Vol 1, 2020 -129837
Publications in other proceedings
-
BrazMedChem 2022
Synthesis and Pharmacological Evaluation of 1,5-dissubstituted-3-amino-1,2,4-triazoles Designed as Cholinesterase Inhibitors, Metal Chelating and Antioxidant for the Treatment of Alzheimer’s Disease
-
BrazMedChem 2022
Synthesis and biological evaluation of new amino-chalcone derivatives as potential anti-prion agents
-
BrazMedChem 2022
Synthesis and Pharmacological Evaluation of New 3-(Imidazo[1,2-a]pyridin-2-yl)-coumarins as Cholinesterase Inhibitors
-
BrazMedChem 2022
Synthesis and pharmacological evaluation of novel triazole-coumarins planned for the treatment of Alzheimer's disease
-
44ª RASBQ
DESENVOLVIMENTO DE INIBIDORES ENZIMÁTICOS MULTIALVO PARA O TRATAMENTO E VÍTIMAS DE ACIDENTES OFÍDICOS: EXPLORANDO SERINA PROTEASES
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
